November 7, 2023 10:29 AM EST
Pharma
Marketing

Mar­ket­ingRx roundup: Sanofi, Re­gen­eron re­new Dupix­ent asth­ma ef­fort; Bausch Health bat­tles sea­son­al af­fec­tive dis­or­der

Beth Snyder Bulik

Senior Editor

Sanofi and Re­gen­eron are switch­ing up the fo­cus in their “Lung­Zone” cam­paign for Dupix­ent, this time high­light­ing asth­ma in chil­dren. This year’s dig­i­tal and video …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

FDA ap­proves Io­n­is’ treat­ment for a rare meta­bol­ic dis­or­der

A service from the Financial Times